title: A step toward more accurate dosing for mercaptopurine in childhood acute lymphoblastic leukemia.
authors.affiliation: Centre for Therapeutic Evaluation of Drugs in Children, Department of Pharmacy, University Hospitals of Leicester, England. Hussain.mulla@uhl-tr.nhs.uk
authors.forename: Hussain
authors.initials: H
authors.lastname: Mulla
authors.forename: Andrew
authors.initials: A
authors.lastname: Leary
authors.forename: Peter
authors.initials: P
authors.lastname: White
authors.forename: Hitesh C
authors.initials: HC
authors.lastname: Pandya
mesh_terms: D000293:Adolescent; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D001682:Biological Availability; D018592:Cross-Over Studies; D006801:Humans; D015122:Mercaptopurine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D008780:Methyltransferases / Q000097:blood; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D013535:Suspensions; D013607:Tablets; D055815:Young Adult
chemical_list: D000964:Antimetabolites, Antineoplastic; D013535:Suspensions; D013607:Tablets; D015122:Mercaptopurine; D008780:Methyltransferases; C022745:thiopurine methyltransferase